Frontolimbic structural changes in borderline personality disorder

https://doi.org/10.1016/j.jpsychires.2007.07.015Get rights and content

Abstract

Objective

Frontolimbic dysfunction is observed in borderline personality disorder (BPD), with responses to emotional stimuli that are exaggerated in the amygdala and impaired in the anterior cingulate cortex (ACC). This pattern of altered function is consistent with animal models of stress responses and depression, where hypertrophic changes in the amygdala and atrophic changes in the ACC are observed. We tested the hypothesis that BPD patients exhibit gross structural changes that parallel the respective increases in amygdala activation and impairment of rostral/subgenual ACC activation.

Methods

Twelve unmedicated outpatients with BPD by DSM-IV and 12 normal control (NC) subjects underwent a high-resolution T1-weighted structural MRI scan. Relative gray matter concentration (GMC) in spatially-normalized images was evaluated by standard voxel-based morphometry, with voxel-wise subject group comparisons by t test constrained to amygdala and rostral/subgenual ACC.

Results

The BPD group was significantly higher than NC in GMC in the amygdala. In contrast, the BPD group showed significantly lower GMC than the NC group in left rostral/subgenual ACC.

Conclusions

This sample of BPD patients exhibits gross structural changes in gray matter in cortical and subcortical limbic regions that parallel the regional distribution of altered functional activation to emotional stimuli among these same subjects. While the histological basis for GMC changes in adult clinical populations is poorly-known at present, the observed pattern is consistent with the direction of change, in animal models of anxiety and depression, of neuronal number and/or morphological complexity in both the amygdala (where it is increased) and ACC (where it is decreased).

Introduction

Borderline personality disorder is a serious, chronic disorder characterized by disturbances of impulse control, affect and interpersonal relationships. The neurobiological basis of the last two symptom domains remains poorly-characterized. However, emerging evidence from functional neuroimaging studies suggests that these symptoms are related to dysfunction of fronto-limbic circuits (Posner et al., 2003). Among subcortical limbic structures, the amygdala mediates the most extensive range of social and emotional processes (LeDoux, 2000, Davidson, 2002). Accordingly, BPD patients exhibit exaggerated amygdala responses to social and emotional stimuli (Donegan et al., 2003, Herpertz et al., 2001, Minzenberg et al., 2007). Among frontal cortical areas in BPD, the anterior cingulate cortex (ACC) shows impaired in vivo serotonin synthesis capacity (Leyton et al., 2001), impaired serotonergic modulation of metabolic activity (Siever et al., 1999, New et al., 2002), and greater deactivation in response to scripts eliciting memories of interpersonal abandonment (Schmahl et al., 2003a). ACC dysfunction in turn may be related to both emotion dysfunction and impaired cognitive control observed in BPD (Posner et al., 2002, Minzenberg, in press). Evidence for these reciprocal changes has been found in post-traumatic stress disorder (PTSD) (Shin et al., 2004), depression (Mayberg et al., 1999) and substance abuse (London et al., 2004), which are disorders related to BPD. We have also found elevated amygdala activation, and impaired modulation of task-related ACC deactivation in response to facial emotion, measured by functional MRI (Minzenberg et al., 2007).

One crucial issue that remains largely unaddressed in the study of frontolimbic dysfunction in BPD is the relationship between altered function and altered structure of these implicated regions. A variety of rodent models of stress and affective disorders have suggested a morphological basis for the functional alterations found in BPD and related disorders (see Radley and Morrison, 2005 for review). For example, chronic immobilization stress is associated with hypertrophic neuronal changes in the basolateral nucleus of the amygdala, including enhanced dendritic arborization (Vyas et al., 2002) and spine density, which parallels the emergence of anxiety-like behavior (Mitra et al., 2005). The dendritic changes may persist after a stress-free period (Vyas et al., 2004). Increased neuronal density in the lateral nucleus of the amygdala is found in adult rats subject to prenatal stress (Salm et al., 2004), and enhanced amygdala neurogenesis may be found in adult rats subject to either social stressors (Fowler et al., 2002) or bilateral olfactory bulbectomy (an established model of depression) (Keilhoff et al., 2006). In contrast, in the ACC and adjacent medial PFC, consistent atrophic changes are found in response to stressors. After restraint stress, decreased length and branching of apical dendrites are observed in layer II/III pyramidal cells in ACC and medial PFC (Radley et al., 2004, Radley et al., 2006, Brown et al., 2005, Cook and Wellman, 2004), which may be reversible (Radley et al., 2006). Apical dendritic reorganization of these neurons also occurs in response to chronic exogenous corticosterone administration (Wellman, 2001). Decreased spine density is also observed in layer II/II pyramidal cells of medial PFC after restraint stress (Radley et al., 2006), daily injections (Seib and Wellman, 2003) and social isolation (Silva-Gomez et al., 2003). This literature indicates that a variety of models of anxiety and depression are associated with changes in neuronal number and morphological complexity, which may be variably persistent. These changes can reasonably be expected to have effects, in predictable directions, on measures of both gross structure and function of these respective brain regions in adults who suffer from these symptoms.

Thus far, the findings of volumetric neuroimaging studies of adult populations with these disorders remains varied. Several groups have reported increased amygdala volumes among patients with bipolar affective disorder, relative to healthy control subjects (Altshuler et al., 1998, Altshuler et al., 2000, Strakowski et al., 1999, Brambilla et al., 2003). Bipolar affective disorder shares many clinical features with BPD, including affective instability, impulsivity and interpersonal disturbances, and may be overrepresented in BPD patients as a comorbid condition (Smith et al., 2004, Magill, 2004). Increases in amygdala volume have also been found in patients experiencing a first episode of major depression, in comparison to both healthy controls (Frodl et al., 2002) and patients with recurrent major depression (Frodl et al., 2003), and in temporal lobe epilepsy patients with comorbid depression (Tebartz van Elst et al., 2000) or dysthymia (Tebartz van Elst et al., 1999), relative to both epilepsy patients without comorbid mood disorders and healthy controls. However, other studies have found no change or reduced volume of the amygdala in major depression and anxiety disorders such as PTSD (reviewed in Anand and Shekhar, 2003, Sheline, 2000). In BPD, some studies have found no change in amygdala volume (Brambilla et al., 2004) while others have found reduced volume (Tebartz van Elst et al., 2003, Rusch et al., 2003, Driessen et al., 2000, Schmahl et al., 2003b). Among these latter studies, one excluded parts of the centromedian nucleus of the amygdala from the analysis (Tebartz van Elst et al., 2003), one employed a comparison group with a high incidence of mood, anxiety or substance use disorders (Schmahl et al., 2003b), and one reported stereotactic coordinates for a maximal gray matter volume difference (with voxel-based morphometry) that appears to be clearly posterior to the amygdala proper (and into the hippocampus), by either the MNI coordinate system or using the Brett-transform to Talairach space (Rusch et al., 2003). Therefore, it remains uncertain whether patients with BPD exhibit changes in amygdala volume relative to healthy control subjects. In contrast, ACC volume appears to be decreased in BPD, in both studies in which it has been examined (Tebartz van Elst et al., 2003, Hazlett et al., 2005), as it is in bipolar affective disorder (Lochhead et al., 2004, Lyoo et al., 2004, Sassi et al., 2004).

The literature addressing animal models of mood and anxiety disorders therefore suggests a morphological basis for functional changes in BPD, and there is some supportive evidence from volumetric studies of adults with mood disorders as well. Given the findings previously reported in the present study sample, of increases in amygdala activation and decreases in ACC activation to expressions of fear, we set out to test whether these functional changes are accompanied by underlying structural changes in these same brain regions. We employed voxel-based morphometry (VBM) in order to test this hypothesis. VBM offers several advantages in this regard. It is an unbiased, fully-automated procedure that involves the registration of each subject’s brain into a standard stereotactic space, to account for global variation in size and shape of individual brains, followed by the segmentation of gray matter from white matter and cerebrospinal fluid (Mechelli et al., 2005, Ashburner and Friston, 2000). The lack of investigator bias is particularly important for measuring the amygdala, which is notoriously difficult to distinguish from adjacent structures in MRI images, with great variation in the criteria that are employed to define it as a result (Brierley et al., 2002). The pre-processing of images in VBM also facilitates the pooling of subjects for between-group comparisons, and facilitates the simultaneous assessment of multiple brain regions. We utilized the “standard” VBM procedure (Mechelli et al., 2005) to obtain measures of gray matter concentration (GMC). We chose to test GMC changes as they may be expected to have a closer relationship to the neuronal morphological changes demonstrated in the animal models (see above).We hypothesized that BPD patients would exhibit GMC that is increased in the amygdala and decreased in the ACC, relative to the healthy control group.

Section snippets

Subjects and clinical measures

This study was designed and carried out in accordance with the Declaration of Helsinki, and approved by the Mount Sinai School of Medicine Institutional Review Board, and all subjects underwent informed consent prior to participation in study procedures. The borderline personality disorder group (BPD) and Normal Control (NC) group were each comprised of 12 adults recruited from the community. The BPD group was not significantly different from the NC group in age (30.3 ± 8 versus 30.7 ± 10 years; p = 

Results

The BPD group exhibited a significant increase in GMC in the bilateral amygdala (Table 1 and Fig. 1). The size, spatial location and peak magnitude of the between-group differences were remarkably similar between each amygdala bilaterally. These were largely centered in the dorso-ventral and medio-lateral dimensions of the amygdala.

In contrast, the BPD group exhibited a significant decrease in GMC in the left rostral/subgenual ACC (Table 1 and Fig. 2). This area has previously shown altered

Discussion

In the present study, we tested group differences in gray matter concentration between a sample of unmedicated outpatients with BPD and a group of healthy control subjects. We hypothesized that the BPD group would exhibit regional GMC changes that parallel the topographic distribution of changes in functional activation to emotional stimuli in these same subjects. In particular, we predicted that the BPD group would show GMC that is increased in the amygdala and decreased in the ACC, pursuant

Conclusion

BPD is characterized by disturbances in frontolimbic activity, with evidence for reciprocal changes in amygdala and rostral/subgenual ACC. The structural basis for these changes may reside in altered gray matter in these regions, with animal models of early stress and depression suggesting hypertrophic and atrophic changes in neurons in the amygdala and ACC, respectively. Future investigations may benefit from directly addressing the hypothesized histopathology underlying these neuroimaging

Conflict of interest

None declared.

Acknowledgements

This work was supported in part by a grant from the Borderline Personality Disorder Research Foundation to Dr. Siever, 1 RO1 MH067918-01A1 from NIMH to Dr. New, the VA VISN3 MIRECC, and 5 M01 RR00071 for the Mount Sinai General Clinical Research Center from the National Center for Research Resources, National Institutes of Health. These sources of support had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the

References (58)

  • L.L. Altshuler et al.

    Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity

    Archives of General Psychiatry

    (1998)
  • L.L. Altshuler et al.

    An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia

    Biological Psychiatry

    (2000)
  • A. Anand et al.

    Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala

    Annals of the New York Academy of Science

    (2003)
  • J. Ashburner et al.

    Voxel-based morphometry – the methods

    Neuroimage

    (2000)
  • P. Brambilla et al.

    MRI investigation of temporal lobe structures in bipolar patients

    Journal of Psychiatric Research

    (2003)
  • P. Brambilla et al.

    Anatomical MRI study of borderline personality disorder patients

    Psychiatry Research: Neuroimaging

    (2004)
  • B. Brierley et al.

    The human amygdala: a systematic review and meta-analysis of volumetric magnetic resonance imaging

    Brain Research Reviews

    (2002)
  • S.M. Brown et al.

    Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex

    Cerebral Cortex

    (2005)
  • S.C. Cook et al.

    Chronic stress alters dendritic morphology in rat medial prefrontal cortex

    Journal of Neurobiology

    (2004)
  • R.J. Davidson

    Anxiety and affective style: role of prefrontal cortex and amygdala

    Biological Psychiatry

    (2002)
  • N.H. Donegan et al.

    Amygdala hyperreactivity in borderline personality disorder: implications for emotional dysregulation

    Biological Psychiatry

    (2003)
  • M. Driessen et al.

    Magnetic resonance imaging volumes of the hippocampus and the amygdala in women with borderline personality disorder and early traumatization

    Archives of General Psychiatry

    (2000)
  • M.B. First et al.

    User’s guide for the structured clinical interview for DSM-IV axis I (SCID-I)

    (1995)
  • C.D. Fowler et al.

    The effects of social environment on adult neurogenesis in the female prairie vole

    Journal of Neurobiology

    (2002)
  • T. Frodl et al.

    Enlargement of the amygdala in patients with a first episode of major depression

    Biological Psychiatry

    (2002)
  • T. Frodl et al.

    Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects

    Biological Psychiatry

    (2003)
  • E.A. Hazlett et al.

    Reduced anterior and posterior cingulate gray matter in borderline personality disorder

    Biological Psychiatry

    (2005)
  • S.C. Herpertz et al.

    Evidence of abnormal amygdala functioning in borderline personality disorder: a functional MRI study

    Biological Psychiatry

    (2001)
  • G. Keilhoff et al.

    Cell proliferation is influenced by bulbectomy and normalized by imipramine treatment in a region-specific manner

    Neuropsychopharmacology

    (2006)
  • J. LeDoux

    Emotion circuits in the brain

    Annual Review of Neuroscience

    (2000)
  • M. Leyton et al.

    Brain regional alpha-[11C] methyl-l-tryptophan trapping in impulsive subjects with borderline personality disorder

    American Journal of Psychiatry

    (2001)
  • R.A. Lochhead et al.

    Regional brain gray matter volume differences in patients with bipolar disorder as assessed by optimized voxel-based morphometry

    Biological Psychiatry

    (2004)
  • N.K. Logothetis et al.

    Interpreting the BOLD signal

    Annual Review of Physiology

    (2004)
  • E.D. London et al.

    Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers

    Archives of General Psychiatry

    (2004)
  • I.K. Lyoo et al.

    Frontal lobe gray matter density decreases in bipolar I disorder

    Biological Psychiatry

    (2004)
  • C.A. Magill

    The boundary between borderline personality disorder and bipolar disorder: current concepts and challenges

    Canadian Journal of Psychiatry

    (2004)
  • H.S. Mayberg et al.

    Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness

    American Journal of Psychiatry

    (1999)
  • Mechelli A, Price CJ, Friston KJ, Ashburner J. Voxel-based morphometry of the human brain: methods and applications....
  • M.J. Minzenberg et al.

    Frontolimbic dysfunction in response to facial emotion in borderline personality disorder: an event-related fMRI study

    Psychiatry Research: Neuroimaging

    (2007)
  • Cited by (110)

    • Genetic modulation of facial emotion recognition in borderline personality disorder

      2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    • The Neurobiology of Borderline Personality Disorder

      2018, Psychiatric Clinics of North America
    View all citing articles on Scopus
    View full text